Surgical pitfalls of excising an intramyocardial lipoma

Slides:



Advertisements
Similar presentations
Of mice and men and surgical transcatheter aortic valve insertion
Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Matthew Williams, DO, Tomas Salerno, MD, Anthony L. Panos, MD 
Alan P. Kypson, MD, David W. Frazier, MD, Jon F. Moran, MD 
Intraosseous lipoma of the rib
Right internal thoracic artery or saphenous vein grafting
Circulating tumor DNA: Solid data from liquid biopsies
Murray H. Kwon, MD  The Journal of Thoracic and Cardiovascular Surgery 
Intrinsic cardiac stem cells are essential for regeneration
Cardiac tumors: To treat or not to treat (or both)?
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Cardiac lipoma arising from left ventricular papillary muscle: Resect or not?  Young Sam Kim, MD, Kyung Hee Lee, MD, PhD, Suk Jin Choi, MD, PhD, Wan Ki.
Abracadabra I, II…HeartMate 3?
Victor van Berkel, MD, PhD 
Multilevel data analysis: What? Why? How?
Marye J. Gleva, MD, Charles B. Huddleston, MD 
Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 
Bicuspid aortic valve aortopathy: One size fits all?
Calcified amorphous tumor of left atrium
Bigger The Journal of Thoracic and Cardiovascular Surgery
Daniel Schmauss, MD, Nicolas Gerber, MSc, Ralf Sodian, MD 
The lord of the rings  Antonio Miceli, MD, PhD 
Jared P. Beller, MD, Irving L. Kron, MD 
Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model  Daniel.
Sinus node structural changes in patients with long-standing chronic atrial fibrillation  Aquilino Hurlé, MD, PhD, Vicente Climent, MD, PhD, Damian Sánchez-Quintana,
Anomalous left coronary artery from the pulmonary artery with an intramural course within the aortic wall: Report of 3 surgical cases  Steven P. Goldberg,
Juan N. Pulido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Support Your Specialty
Michael Mack, MD, David Taggart, MD 
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
For everything there is a season
Military surgeons just want to have fun
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc 
Niv Ad, MD, Lawrence M. Wei, MD 
Frank C. Spencer, MD, FACS, pioneering cardiothoracic surgeon
Attachment disorder in thoracoabdominal surgery
Cardiac surgery in patients with a porcelain aorta
We are the company we keep: The importance of the tumor microenvironment  Sai Yendamuri, MD, FACS  The Journal of Thoracic and Cardiovascular Surgery 
Cardiac myxoma: Simplifying a “complex” case
Commentary: Do the right thing! Ethical versus legal
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
The thoracoabdominal saga and heroes
Who is your plastic surgeon
James I. Fann, MD, John E. Connolly, MD 
Ralph S. Mosca, MD  The Journal of Thoracic and Cardiovascular Surgery 
If airlines can do it, we can too…
Innovation in cardiothoracic surgical training
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Early extubation after cardiac surgery: The evolution continues
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Bicuspid aortopathy: Seeing the forest for the trees
Should it stay or should it go?
Concomitant giant coronary artery and coronary sinus aneurysms
“The more things change…”: The challenges ahead
Commentary: Judgment day: Should you add atrial fibrillation ablation?
Commentary: Avoiding acute kidney injury after cardiac operations: Searching for the holy grail is not easy  Victor A. Ferraris, MD, PhD  The Journal.
Toll-like receptor 4 inhibition attenuates ischemia-reperfusion injury in rats: Will it work in human beings?  Chadrick E. Denlinger, MD  The Journal.
First in line for robotic surgery: Would you want to know?
Apples remain apples NO matter what
A large international single-center case-series of coronary artery fistulas in children: When high clinical research standards adopted globally create.
Preoperative PFTs: The answer is blowing in the wind
Who should decide margin length in pulmonary excision of lung cancer?
Journal changes and initiatives
Edward Y. Chan, MD, Michael J. Reardon, MD 
Calpain inhibitors: The aspirin of the 21st century?
Deciding how much to pay for effective care
Presentation transcript:

Surgical pitfalls of excising an intramyocardial lipoma Abdallah K. Alameddine, MD, Victor K. Alimov, MD, George S. Turner, CCP, David W. Deaton, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 141, Issue 2, Pages 592-594 (February 2011) DOI: 10.1016/j.jtcvs.2010.06.043 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Right atrial mass (T) as seen during surgical intervention. The black arrow indicates the right coronary artery. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 592-594DOI: (10.1016/j.jtcvs.2010.06.043) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Surgical specimens (A and B): the white arrow indicates the osteum of the diverticulum. Histopathologically (C and D), there was no adipocytic or stromal nuclear atypia or hyperchromatism. Atypical stromal cells other than hypertrophic myocardial elements were not identified. Just focally, the lesion appears to be infiltrating cardiac muscle, but most of the lesion is devoid of any muscular component; it would generally be expected to see more diffuse/infiltrative involvement of the cardiac muscle in lipomatous hypertrophy. Immunohistochemical studies were performed, and the results were as follows: desmin, positive in myocytes within the mature adipose tissue of the mass; myoglobin, positive in myocytes within the mature adipose tissue of the mass; myogenin, negative in myocytes within the mature adipose tissue of the mass; HMB-45, negative in stromal elements within mature adipose tissue; melan-A, negative in stromal elements within mature adipose tissue; estrogen receptor, negative in cellular elements of the tumor; and progesterone receptor, negative in cellular elements of the tumor. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 592-594DOI: (10.1016/j.jtcvs.2010.06.043) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions